Alpine Immune Sciences, Inc.
ALPNDelisted May 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626199
Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Alpine Immune Sciences, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 133
- +46 vs. Q3 2023
- Shares held
- 58.9M
- +19.7M (+50.3%) vs. Q3 2023
- Total value
- $1.12B
- +$674.1M (+150.1%) vs. Q3 2023
- New holders
- 55
- 62 more added
- Sold out
- 9
- 10 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 180 | $2.56B |
| Q4 2023 | 133 | $1.12B |
| Q3 2023 | 88 | $525.8M |
| Q2 2023 | 77 | $449.3M |
| Q1 2023 | 61 | $319.4M |
| Q4 2022 | 64 | $300.8M |
| Q3 2022 | 70 | $284.0M |
| Q2 2022 | 58 | $204.4M |
| Q1 2022 | 56 | $221.8M |
| Q4 2021 | 53 | $257.1M |
| Q3 2021 | 44 | $163.5M |
| Q2 2021 | 47 | $118.5M |
| Q1 2021 | 48 | $145.0M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Alpine Immune Sciences, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Advisers, LP | 264,075 | $5.03M | 0.01% | +18,000+7.3% | Added |
| Millennium Management LLC | 273,066 | $5.20M | 0.00% | +190,140+229.3% | Added |
| D. E. Shaw & Co., Inc. | 295,542 | $5.63M | 0.01% | +246,911+507.7% | Added |
| Northern Trust Corp | 296,695 | $5.66M | 0.00% | +26,271+9.7% | Added |
| Charles Schwab Investment Management Inc | 297,452 | $5.67M | 0.00% | +63,196+27.0% | Added |
| Silverarc Capital Management, LLC | 297,789 | $5.68M | 1.75% | +297,789 | New |
| Ally Bridge Group (NY) LLC | 357,271 | $6.81M | 4.90% | +357,271 | New |
| Walleye Capital LLC | 365,940 | $6.97M | 0.10% | +179,667+96.5% | Added |
| Two Sigma Investments, LP | 378,413 | $7.21M | 0.02% | +187,824+98.5% | Added |
| Candriam Luxembourg S.C.A. | 470,000 | $8.96M | 0.06% | +470,000 | New |
| Ikarian Capital, LLC | 487,248 | $9.29M | 2.54% | +487,248 | New |
| Janus Henderson Group PLC | 583,239 | $11.1M | 0.01% | +583,239 | New |
| Adage Capital Partners GP, L.L.C. | 714,590 | $13.6M | 0.03% | +714,590 | New |
| Morgan Stanley | 718,741 | $13.7M | 0.00% | +665,268+1,244.1% | Added |
| Geode Capital Management, LLC | 764,347 | $14.6M | 0.00% | +135,422+21.5% | Added |
| Vivo Capital, LLC | 819,275 | $15.6M | 1.28% | −95,638−10.5% | Reduced |
| Citadel Advisors LLC | 875,257 | $16.7M | 0.02% | +847,083+3,006.6% | Added |
| Woodline Partners LP | 1,000,106 | $19.1M | 0.21% | −38,671−3.7% | Reduced |
| Franklin Resources Inc | 1,220,333 | $23.3M | 0.01% | +1,220,333 | New |
| Octagon Capital Advisors LP | 1,241,300 | $23.7M | 3.79% | +491,300+65.5% | Added |
| State Street Corp | 1,390,029 | $26.5M | 0.00% | +784,484+129.6% | Added |
| Commodore Capital LP | 1,610,000 | $30.7M | 2.68% | +285,000+21.5% | Added |
| Price T Rowe Associates Inc | 1,687,278 | $32.2M | 0.00% | +290,834+20.8% | Added |
| Vanguard Group Inc | 2,234,767 | $42.6M | 0.00% | +759,888+51.5% | Added |
| OrbiMed Advisors LLC | 2,535,245 | $48.3M | 0.97% | −1,546,347−37.9% | Reduced |
| Cormorant Asset Management, LP | 2,550,000 | $48.6M | 2.33% | +650,000+34.2% | Added |
| BlackRock Inc. | 3,058,498 | $58.3M | 0.00% | +706,581+30.0% | Added |
| Frazier Life Sciences Management, L.P. | 3,131,008 | $59.7M | 3.19% | +145,251+4.9% | Added |
| Paradigm Biocapital Advisors LP | 3,176,743 | $60.5M | 2.84% | +755,000+31.2% | Added |
| Great Point Partners LLC | 3,703,433 | $70.6M | 12.03% | +624,800+20.3% | Added |
| Lynx1 Capital Management LP | 3,813,926 | $72.7M | 28.58% | +1,409,312+58.6% | Added |
| Ra Capital Management, L.P. | 4,909,763 | $93.6M | 1.46% | +218,585+4.7% | Added |
| Decheng Capital LLC | 7,083,288 | $135.0M | 37.72% | +7,083,288 | New |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −664,132−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −657,280−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −314,029−100.0% | Sold out |
| Omega Fund Management, LLC | 0 | $0 | 0.00% | −153,700−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −90,937−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −88,073−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −13,744−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −9,927−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −2,273−100.0% | Sold out |
| Decheng Capital Management III (Cayman), LLC | – | – | – | – | Not filed |